血液検査による炎症指数:胃潰瘍におけるリスク分層化のための非侵襲的補助剤
Sevgi Kalkanli Tas1, Furkan Aydın2, Duygu Kirkik3
1Department of Immunology, Faculty of Hamidiye Medicine, University of Health Sciences, Istanbul 34668, Türkiye. skalkanlitas@gmail.com.
World journal of gastroenterology
|February 16, 2026
まとめ
単純な血液検査は,胃潰瘍 (GU) のリスクが高い個人を特定するのに役立ちます. 全身血液検査の炎症マーカーは,全身炎症反応指数のように,GUの早期発見と管理に希望を示しています.
科学分野:
- 胃腸内科 胃腸内科
- 血液学 ヘマトロジ
- 免疫学 免疫学とは
背景:
- 胃潰瘍 (GU) は,深刻な合併症を伴う重要な世界的な健康問題です.
- ヘリコバクター・ピロリとNSAIDは既知の原因であるが,GUの病原性における全身性炎症の役割は十分に調査されていない.
研究 の 目的:
- 全血液検査 (CBC) に由来する炎症バイオマーカーと胃潰瘍の罹患率との関連を調べる.
- GUのリスクが高い個人の早期発見に役立つ特定の血液学的マーカーを特定する.
主な方法:
- GUの流行に関連したCBCパラメータの横断分析.
- 中性素対リンパ球比 (NLR),単細胞対リンパ球比 (MLR),全身性炎症反応指数 (SIRI) などの炎症指数の評価.
主要な成果:
- 完全血液検査に由来する炎症バイオマーカーは,GUの罹患率と有意に関連しています.
- システミック炎症反応指数 (SIRI) は,GUを特定するための最も差別的なマーカーとして浮上しました.
- ルーティン血液学的パラメータは,リスクの早期識別のための費用対効果の高い,アクセシブルな方法を提供します.
結論:
- SIRI,NLR,MLRを含むCBCから派生した単純な炎症指標は,胃潰瘍の診断補助薬として潜在的可能性を示している.
- これらのマーカーは,免疫不調と酸化ストレスを含むGUの病原性についての洞察を提供することができます.
- 潰瘍再発に対するその予測的価値を探求し,リスクの階層化と管理を改善するために精度の胃腸内科に統合するためにさらなる研究が必要です.
さらに関連する動画
09:11Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
Published on: February 14, 2021
10.6K
05:50Author Spotlight: Point-of-Care Ultrasound for Gastric Content Assessment and Risk Stratification in Perioperative Care
Published on: September 22, 2023
4.5K
関連する概念動画
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
649
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
649
01:30Peptic Ulcer Disease I: Introduction
900
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
900
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
915
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
915
01:23Gastritis III: Clinical Manifestations and Management
1.4K
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.4K
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
1.2K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.2K
01:26Peptic Ulcer Disease IV: Management
546
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
546